These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 6137095)
1. [Sulpiride (Dogmatil). A new antipsychosis agent (neuroleptic) with few side effects]. Gerlach J Ugeskr Laeger; 1983 Aug; 145(34):2611-2. PubMed ID: 6137095 [No Abstract] [Full Text] [Related]
2. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine. Jagadheesan K; Muirhead D Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830 [No Abstract] [Full Text] [Related]
4. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode]. Barrimi M; El Ghazouani F; Zaimi O; Oneib B Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559 [No Abstract] [Full Text] [Related]
5. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report. Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977 [No Abstract] [Full Text] [Related]
6. [Sultopride: a new powerful neuroleptic (author's transl)]. Anglade P; Baraer J Sem Hop; 1979 Jan 8-15; 55(1-2):63-7. PubMed ID: 34217 [TBL] [Abstract][Full Text] [Related]
7. [Long-term dogmatil therapy in major psychiatry]. Szymonowicz R Sem Hop; 1983 May; 59(19):1468-70. PubMed ID: 6310763 [TBL] [Abstract][Full Text] [Related]
8. Catatonia, neuroleptics and brain damage--a case report. Chandran M; El-Shazly M J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406 [TBL] [Abstract][Full Text] [Related]
9. [Solian: evaluation of 10 years' experimentation and clinical practice]. Baldauf A; Metzger JY; Sichel JP Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244 [No Abstract] [Full Text] [Related]
10. [Sulpiride: an atypical neuroleptic with a wide spectrum of therapeutic claims]. Wasieczko A; Wasieczko Z Psychiatr Pol; 1996; 30(6):1009-16. PubMed ID: 9132763 [No Abstract] [Full Text] [Related]
11. [Clinico-statistical study of the effects of sulpiride, a new psychopharmacologic agent]. Bente D; Koeller DM; Koufen H; Pietzcker A; Schulte PW Arzneimittelforschung; 1974 Jan; 24(1):107-11. PubMed ID: 4594226 [No Abstract] [Full Text] [Related]
12. [Treatment of the side effects of antipsychotic drug therapy]. Bernstein JG Acta Psiquiatr Psicol Am Lat; 1981 Mar; 27(1):72-8. PubMed ID: 6127877 [No Abstract] [Full Text] [Related]
13. Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. Stip E J Psychiatry Neurosci; 2000 Mar; 25(2):137-53. PubMed ID: 10740987 [TBL] [Abstract][Full Text] [Related]
14. Clozapine treatment and neuroleptic malignant syndrome. Doan RJ; Callaghan WD Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077 [No Abstract] [Full Text] [Related]
15. [Changes in the endocrine system in the course of sulpiride therapy]. Roś LT Pol Merkur Lekarski; 2001 Dec; 11(66):532-4. PubMed ID: 11899856 [TBL] [Abstract][Full Text] [Related]
16. [Depot neuroleptic agents]. Dröes JT Ned Tijdschr Geneeskd; 1986 Dec; 130(50):2251-5. PubMed ID: 2880304 [No Abstract] [Full Text] [Related]
17. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
18. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report. Croissant B; Hermann D; Olbrich R Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466 [TBL] [Abstract][Full Text] [Related]